1-((2R,4S,5R)-4-Fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACXSKQ350
CAS No. :
41107-56-6
Molecular Formula :
C9H11FN2O4
Molecular Weight :
230.20

IUPAC Name:1-((2R,4S,5R)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

1-((2R,4S,5R)-4-Fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$75.00Login to see priceInquiryInquiry
25mg95%$229.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((2R,4S,5R)-4-Fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
IUPAC Name1-((2R,4S,5R)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Molecular FormulaC9H11FN2O4
Molecular Weight230.20
SMILESOC[C@@H]1[C@@H](F)C[C@H](N2C(NC(C=C2)=O)=O)O1
InChI KeyBKIUEHLYJFLWPK-SHYZEUOFSA-N
Synonym2',3'-Dideoxy-3'-fluorouridine, 95% | 1-[(2R,4S,5R)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione | 5-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran | 1-[(2R,4S,5R)-4-fluoro-5-(hydroxymethyl)oxolan-2
CAS No.41107-56-6
PubChem CID162450

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXSKQ350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXSKQ350 route product structure diagram
    ACXSKQ35041107-56-6
Inquiry

2. ACXSKQ350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXSKQ350 route product structure diagram
    ACXSKQ35041107-56-6
Inquiry

Comments (0)